906079-93-4 Usage
Description
3-ethoxy-5-(hydroxyMethyl)phenol, also known as Vanillyl alcohol ethereal, is a phenolic derivative with the molecular formula C9H12O3. It is an organic compound that possesses a mildly sweet, smoky odor and is commonly found in a variety of plants. 3-ethoxy-5-(hydroxyMethyl)phenol has potential applications in various industries, including the food, pharmaceutical, and health sectors.
Uses
Used in Food Industry:
3-ethoxy-5-(hydroxyMethyl)phenol is used as a flavoring agent for its unique taste and odor, enhancing the sensory experience of various food products.
Used in Pharmaceutical Industry:
3-ethoxy-5-(hydroxyMethyl)phenol is used as a precursor to the drug vanillin, which has potential applications in the development of medications and pharmaceutical products.
Used in Health and Wellness Applications:
Due to its antioxidant properties, 3-ethoxy-5-(hydroxyMethyl)phenol is studied for its potential health benefits, which may include the prevention of oxidative stress and related health issues.
Check Digit Verification of cas no
The CAS Registry Mumber 906079-93-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,6,0,7 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 906079-93:
(8*9)+(7*0)+(6*6)+(5*0)+(4*7)+(3*9)+(2*9)+(1*3)=184
184 % 10 = 4
So 906079-93-4 is a valid CAS Registry Number.
906079-93-4Relevant articles and documents
Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
-
Page/Page column 40, (2010/11/23)
This invention is concerned with compounds of the formula wherein A, B1, B2, R1, R2 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors
Zbinden, Katrin Groebke,Obst-Sander, Ulrike,Hilpert, Kurt,Kuehne, Holger,Banner, David W.,Boehm, Hans-Joachim,Stahl, Martin,Ackermann, Jean,Alig, Leo,Weber, Lutz,Wessel, Hans Peter,Riederer, Markus A.,Tschopp, Thomas B.,Lave, Thierry
, p. 5344 - 5352 (2007/10/03)
We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor VIIa inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway.